packageCaplacizumab

caplacizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Caplacizumab, a monoclonal antibody antithrombotic, is used to treat acquired thrombotic thrombocytopenic purpura. It is authorised in the European Union and is also under investigation for other uses.

Summary written by glm-5.3-flash from Wikidata Q5036030 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:caplacizumab
ATC codes:B01AX07
DrugBank:DB06081
Wikidata:Q5036030
molar mass:27880 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown